SCHEMBL10705145

SCHEMBL10705145

COc1ccc(Cc2ncc(C(=O)O)c3cc(OC)c(OC)cc23)cc1OC

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 13/20 0.56
PDE3B Q13370 7/20 0.56
PDE3A Q14432 7/20 0.56
CYP3A4 P08684 3/20 0.56
USP2 O75604 2/20 0.56
ALDH1A1 P00352 2/20 0.56
LMNA P02545 2/20 0.56
MAPK1 P28482 2/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
HIF1A Q16665 2/20 0.56
CYP2C9 P11712 2/20 0.56
TSHR P16473 2/20 0.56
CYP2C19 P33261 2/20 0.56
PDE2A O00408 1/20 0.56
ABCC4 O15439 1/20 0.56
PDE5A O76074 1/20 0.56
ABCB11 O95342 1/20 0.56
CYP1A2 P05177 1/20 0.56
CYP2D6 P10635 1/20 0.56
ALOX15 P16050 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11001937 0.88 PDE10A (0.55) PDE10APDE3BPDE3ACYP3A4USP2
SCHEMBL27655116 0.88 DPP4 (0.50) PDE10APDE3BPDE3ANPSR1MAPT
SCHEMBL11003403 0.85 DPP4 (0.70) PDE10APDE3BPDE3ACYP3A4USP2
SCHEMBL10705147 0.83 PDE10A (0.55) PDE10APDE3BPDE3ACYP3A4USP2
SCHEMBL3360594 0.81 DPP4 (0.71) DPP4
Methane SCHEMBL10994504 0.80 PDE10A (0.60) PDE10APDE3BPDE3ACYP3A4USP2
SCHEMBL10704822 0.78 DPP4 (0.64) PDE10APDE3BPDE3ACYP3A4USP2
SCHEMBL10998093 0.78 PDE10A (0.62) PDE10APDE3BPDE3ACYP3A4USP2
Papaverine SCHEMBL28508832 0.77 PDE10A (0.85) PDE10APDE3BPDE3ACYP3A4USP2
SCHEMBL14859662 0.77 CYP3A4 (0.40) PDE10APDE3BPDE3ACYP3A4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4559403-A FOR TREATMENT OF CEREBRAL AND CARDIAC ISCHEMIAS HOFFMANN-LA ROCHE INC. (US) 1985-12-17 US claimed
EP-0126480-B1 SUBSTITUTED ISOQUINOLINE DERIVATIVES, METHOD FOR THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1988-01-20 EP disclosed
US-4559403-A FOR TREATMENT OF CEREBRAL AND CARDIAC ISCHEMIAS HOFFMANN-LA ROCHE INC. (US) 1985-12-17 US disclosed
US-4544657-A ANTISCHEMIC AGENTS HOFFMANN-LA ROCHE INC. (US) 1985-10-01 US disclosed
EP-0126480-A1 Substituted isoquinoline derivatives, method for their preparation, and pharmaceutical compositions containing these compounds F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1984-11-28 EP disclosed